Suchergebnisse - Alex Bataller
- Treffer 1 - 6 von 6
-
1
A retrospective study of outcomes across time and treatment regimens in newly diagnosed, FMS‐like tyrosine kinase 3 (FLT3)‐mutated acute myeloid leukemia Autoría: Alexandre Bazinet, Alex Bataller, Tapan Kadia, Naval Daver, Nicholas J. Short, Musa Yilmaz, Koji Sasaki, Courtney D. DiNardo, Gautam M. Borthakur, Ghayas Issa, Ian Bouligny, Sherry Pierce, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian
Veröffentlicht 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups Autoría: Alex Bataller, Courtney D. DiNardo, Alexandre Bazinet, Naval G. Daver, Abhishek Maiti, Gautam Borthakur, Nicholas Short, Koji Sasaki, Elias J. Jabbour, Ghayas C. Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban‐Bravo, Sanam Loghavi, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian, Tapan M. Kadia
Veröffentlicht 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage Autoría: Georgina Gener‐Ricos, Alex Bataller, Juan Jose Rodriguez‐Sevilla, Kelly S. Chien, Andres E. Quesada, Emmanuel Almanza‐Huante, Danielle Hammond, Koji Sasaki, Courtney DiNardo, Tapan Kadia, Naval Daver, Gautam Borthakur, Ghayas C. Issa, Nicholas J. Short, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo
Veröffentlicht 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies Autoría: Wei‐Ying Jen, Sanam Loghavi, Alexandre Bazinet, Alex Bataller, Ian Bouligny, Naval G. Daver, Ghayas C. Issa, Naszrin Arani, Emmanuel Almanza Huante, Abhishek Maiti, Guillermo Montalban‐Bravo, Gautam Borthakur, Nicholas J. Short, Sherry Pierce, Elias Jabbour, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian, Courtney D. DiNardo, Tapan M. Kadia
Veröffentlicht 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
5
A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia Autoría: Tapan M. Kadia, Wei‐Ying Jen, Alex Bataller, Alexandre Bazinet, Gautam Borthakur, Elias Jabbour, Wei Qiao, Nicholas J. Short, Koichi Takahashi, Ghayas C. Issa, Courtney D. DiNardo, Guillermo Montalban‐Bravo, Naveen Pemmaraju, Andrew Tran, Vanthana Bharathi, Sanam Loghavi, Amin M. Alousi, Uday Popat, Naval G. Daver, Farhad Ravandi, Hagop M. Kantarjian
Veröffentlicht 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
6
Cladribine With Low‐Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia Autoría: Tapan M. Kadia, Alex Bataller, Alexandre Bazinet, Gautam Borthakur, Naval Daver, Nicholas J. Short, Courtney DiNardo, Elias Jabbour, Caitlin R. Rausch, Ghayas C. Issa, Naveen Pemmaraju, Maro Ohanian, Abhishek Maiti, Guillermo Montalban‐Bravo, Koji Sasaki, Ian M. Bouligny, Musa Yilmaz, Fadi G. Haddad, Lucia Masarova, Kelly Chien, Yesid Alvarado, Nitin Jain, Uday Popat, Elizabeth Shpall, Sanam Loghavi, Wei Qiao, Xuemei Wang, Guillermo Garcia‐Manero, Farhad Ravandi, Hagop M. Kantarjian
Veröffentlicht 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso